Deputy Speaker, the issue of focusing on the quality of medicines which are affordable, which are effective, is an issue that will always be with us all the time.
When the presidential health summit was convened we had the co- operation of those in the industry to ensure that we receive high quality medicines, but at the same time we have to look at all the available mechanisms to ensure that within the country we can have access to such medicines.
So, the SA Health Products Regulatory Authority is looking at clearing the backlog so that we can process as many of the applications for licenses wherein it creates an opportunity for more affordable medicine where there's more competition and there's proper monitoring of the quality and efficacy of drugs, so that, ultimately, the drugs are available more as a basis on which we manage health care and then we cannot be compromised t=by the fact that the drugs are completely unaffordable.
So, that process is something that we are going to be engaged in on a continuous basis. Thank you.